Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/33949
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | SANTANA, Fernanda P. R. | |
dc.contributor.author | SILVA, Rafael C. da | |
dc.contributor.author | GRECCO, Simone dos S. | |
dc.contributor.author | PINHEIRO, Aruana J. M. C. R. | |
dc.contributor.author | CAPERUTO, Luciana C. | |
dc.contributor.author | ARANTES-COSTA, Fernanda M. | |
dc.contributor.author | CLAUDIO, Samuel R. | |
dc.contributor.author | YOSHIZAKI, Kelly | |
dc.contributor.author | MACCHIONE, Mariangela | |
dc.contributor.author | RIBEIRO, Daniel A. | |
dc.contributor.author | TIBERIO, Iolanda F. L. C. | |
dc.contributor.author | LIMA-NETO, Lidio G. | |
dc.contributor.author | LAGO, Joao H. G. | |
dc.contributor.author | PRADO, Carla M. | |
dc.date.accessioned | 2019-11-06T18:45:50Z | - |
dc.date.available | 2019-11-06T18:45:50Z | - |
dc.date.issued | 2019 | |
dc.identifier.citation | MEDIATORS OF INFLAMMATION, v.2019, article ID 1356356, 14p, 2019 | |
dc.identifier.issn | 0962-9351 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/33949 | - |
dc.description.abstract | Asthma allergic disease is caused by airway chronic inflammation. Some intracellular signaling pathways, such as MAPK and STAT3-SOCS3, are involved in the control of airway inflammation in asthma. The flavonoid sakuranetin demonstrated an anti-inflammatory effect in different asthma models. Our aim was to clarify how sakuranetin treatment affects MAPK and STAT3-SOCS3 pathways in a murine experimental asthma model. Mice were submitted to an asthma ovalbumin-induction protocol and were treated with vehicle, sakuranetin, or dexamethasone. We assayed the inflammatory profile, mucus production, and serum antibody, STAT3-SOCS3, and MAPK levels in the lungs. Morphological alterations were also evaluated in the liver. LPS-stimulated RAW 264.7 cells were used to evaluate the effects of sakuranetin on nitric oxide (NO) and cytokine production. In vivo, sakuranetin treatment reduced serum IgE levels, lung inflammation (eosinophils, neutrophils, and Th2/Th17 cytokines), and respiratory epithelial mucus production in ovalbumin-sensitized animals. Considering possible mechanisms, sakuranetin inhibits the activation of ERK1/2, JNK, p38, and STAT3 in the lungs. No alterations were found in the liver for treated animals. Sakuranetin did not modify in vitro cell viability in RAW 264.7 and reduced NO release and gene expression of IL-1 beta and IL-6 induced by LPS in these cells. In conclusion, our data showed that the inhibitory effects of sakuranetin on eosinophilic lung inflammation can be due to the inhibition of Th2 and Th17 cytokines and the inhibition of MAPK and STAT3 pathways, reinforcing the idea that sakuranetin can be considered a relevant candidate for the treatment of inflammatory allergic airway disease. | eng |
dc.description.sponsorship | Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasil (CAPES) [001] | |
dc.description.sponsorship | Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2018/06088-0, 2014/25689-4] | |
dc.description.sponsorship | National Council for Technologic and Scientific Development (CNPq)National Council for Scientific and Technological Development (CNPq) [306278/2015-4] | |
dc.language.iso | eng | |
dc.publisher | HINDAWI LTD | eng |
dc.relation.ispartof | Mediators of Inflammation | |
dc.rights | openAccess | eng |
dc.subject.other | activated protein-kinase | eng |
dc.subject.other | in-vivo | eng |
dc.subject.other | murine model | eng |
dc.subject.other | asthma | eng |
dc.subject.other | lung | eng |
dc.subject.other | cells | eng |
dc.subject.other | th2 | eng |
dc.subject.other | flavonoids | eng |
dc.subject.other | generation | eng |
dc.subject.other | mucus | eng |
dc.title | Inhibition of MAPK and STAT3-SOCS3 by Sakuranetin Attenuated Chronic Allergic Airway Inflammation in Mice | eng |
dc.type | article | eng |
dc.rights.holder | Copyright HINDAWI LTD | eng |
dc.identifier.doi | 10.1155/2019/1356356 | |
dc.identifier.pmid | 31565031 | |
dc.subject.wos | Cell Biology | eng |
dc.subject.wos | Immunology | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
hcfmusp.author.external | SANTANA, Fernanda P. R.:Univ Fed Sao Paulo, Dept Biol Sci, Diadema, SP, Brazil; Univ Sao Paulo, Sch Med, Dept Med, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | SILVA, Rafael C. da:Univ Fed Sao Paulo, Dept Biol Sci, Diadema, SP, Brazil; Univ Fed Sao Paulo, Dept Biosci, Santos, Brazil | |
hcfmusp.author.external | GRECCO, Simone dos S.:Univ Anhanguera Sao Paulo, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | PINHEIRO, Aruana J. M. C. R.:Univ CEUMA, Sao Luis, MA, Brazil; Programa Posgrad Rede BIONORTE, Rio Branco, Brazil | |
hcfmusp.author.external | CAPERUTO, Luciana C.:Univ Fed Sao Paulo, Dept Biol Sci, Diadema, SP, Brazil | |
hcfmusp.author.external | CLAUDIO, Samuel R.:Univ Fed Sao Paulo, Dept Biosci, Santos, Brazil | |
hcfmusp.author.external | RIBEIRO, Daniel A.:Univ Fed Sao Paulo, Dept Biosci, Santos, Brazil | |
hcfmusp.author.external | LIMA-NETO, Lidio G.:Univ CEUMA, Sao Luis, MA, Brazil; Programa Posgrad Rede BIONORTE, Rio Branco, Brazil | |
hcfmusp.author.external | LAGO, Joao H. G.:Fed Univ ABC, Ctr Nat Sci & Humanities, Santo Andre, SP, Brazil | |
hcfmusp.description.articlenumber | 1356356 | |
hcfmusp.description.volume | 2019 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.id | WOS:000486441200002 | |
hcfmusp.origem.id | 2-s2.0-85072538647 | |
hcfmusp.publisher.city | LONDON | eng |
hcfmusp.publisher.country | ENGLAND | eng |
hcfmusp.relation.reference | Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003 | eng |
hcfmusp.relation.reference | Bruggemann TR, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00718 | eng |
hcfmusp.relation.reference | Caperuto LC, 2008, ENDOCRINOLOGY, V149, P6326, DOI 10.1210/en.2008-0655 | eng |
hcfmusp.relation.reference | Chen J, 2013, J ETHNOPHARMACOL, V148, P835, DOI 10.1016/j.jep.2013.05.020 | eng |
hcfmusp.relation.reference | Chen SM, 2014, BIOCHEM CELL BIOL, V92, P397, DOI 10.1139/bcb-2014-0008 | eng |
hcfmusp.relation.reference | Chialda L, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-36 | eng |
hcfmusp.relation.reference | Christianson CA, 2013, CURR OPIN ALLERGY CL, V13, P100, DOI 10.1097/ACI.0b013e32835c168e | eng |
hcfmusp.relation.reference | Pinheiro AJMCR, 2018, J IMMUNOL RES, DOI 10.1155/2018/6879183 | eng |
hcfmusp.relation.reference | Dahan A, 2004, EUR J CLIN NUTR, V58, P1, DOI 10.1038/sj.ejcn.1601736 | eng |
hcfmusp.relation.reference | Daviskas E, 2006, J AEROSOL MED, V19, P100, DOI 10.1089/jam.2006.19.100 | eng |
hcfmusp.relation.reference | de Oliveira JFF, 2013, INFLAMM RES, V62, P971, DOI 10.1007/s00011-013-0659-3 | eng |
hcfmusp.relation.reference | Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133 | eng |
hcfmusp.relation.reference | Duan W, 2004, J IMMUNOL, V172, P7053, DOI 10.4049/jimmunol.172.11.7053 | eng |
hcfmusp.relation.reference | Gavett SH, 1997, AM J PHYSIOL-LUNG C, V272, pL253 | eng |
hcfmusp.relation.reference | Gavino AC, 2016, ALLERGY, V71, P1684, DOI 10.1111/all.12937 | eng |
hcfmusp.relation.reference | GINA, 2018, GLOBAL STRATEGY ASTH | eng |
hcfmusp.relation.reference | Grecco SD, 2012, EXP PARASITOL, V130, P141, DOI 10.1016/j.exppara.2011.11.002 | eng |
hcfmusp.relation.reference | Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313 | eng |
hcfmusp.relation.reference | Hasegawa T, 2017, EUR CYTOKINE NETW, V28, P8, DOI 10.1684/ecn.2017.0390 | eng |
hcfmusp.relation.reference | Hernandez V, 2007, LIFE SCI, V81, P480, DOI 10.1016/j.lfs.2007.06.006 | eng |
hcfmusp.relation.reference | Huang L, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1436-4 | eng |
hcfmusp.relation.reference | Bittencourt-Mernak MI, 2017, AM J PHYSIOL-LUNG C, V312, pL217, DOI 10.1152/ajplung.00444.2015 | eng |
hcfmusp.relation.reference | Jang TY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197594 | eng |
hcfmusp.relation.reference | Khorasanizadeh M, 2017, PHARMACOL THERAPEUT, V174, P112, DOI 10.1016/j.pharmthera.2017.02.024 | eng |
hcfmusp.relation.reference | Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x | eng |
hcfmusp.relation.reference | Kim KY, 2016, EVID-BASED COMPL ALT, DOI 10.1155/2016/9824203 | eng |
hcfmusp.relation.reference | Kujime K, 2000, J IMMUNOL, V164, P3222, DOI 10.4049/jimmunol.164.6.3222 | eng |
hcfmusp.relation.reference | LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921 | eng |
hcfmusp.relation.reference | Li JM, 2013, FITOTERAPIA, V91, P298, DOI 10.1016/j.fitote.2013.09.009 | eng |
hcfmusp.relation.reference | Martinez-Rivera C, 2018, RESP MED, V135, P22, DOI 10.1016/j.rmed.2017.12.013 | eng |
hcfmusp.relation.reference | MEDURI GU, 1995, CHEST, V108, P1303, DOI 10.1378/chest.108.5.1303 | eng |
hcfmusp.relation.reference | Moon YJ, 2006, TOXICOL IN VITRO, V20, P187, DOI 10.1016/j.tiv.2005.06.048 | eng |
hcfmusp.relation.reference | Murphy DM, 2010, CHEST, V137, P1417, DOI 10.1378/chest.09-1895 | eng |
hcfmusp.relation.reference | Zafra MP, 2015, INT J MOL SCI, V16, P5434, DOI 10.3390/ijms16035434 | eng |
hcfmusp.relation.reference | Sakoda CPP, 2016, ACTA HISTOCHEM, V118, P615, DOI 10.1016/j.acthis.2016.07.001 | eng |
hcfmusp.relation.reference | Possa SS, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00046 | eng |
hcfmusp.relation.reference | Pu QQ, 2019, FASEB J, V33, P1074, DOI 10.1096/fj.201801085R | eng |
hcfmusp.relation.reference | Santana FPR, 2016, MEDIAT INFLAMM, DOI 10.1155/2016/2348968 | eng |
hcfmusp.relation.reference | Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896 | eng |
hcfmusp.relation.reference | Sjolander A, 1998, J IMMUNOL, V160, P3949 | eng |
hcfmusp.relation.reference | Sun WJ, 2018, EXP CELL RES, V371, P196, DOI 10.1016/j.yexcr.2018.08.010 | eng |
hcfmusp.relation.reference | Taguchi L, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0233-3 | eng |
hcfmusp.relation.reference | Tas SW, 2016, NAT REV RHEUMATOL, V12, P111, DOI 10.1038/nrrheum.2015.164 | eng |
hcfmusp.relation.reference | Toledo AC, 2013, BRIT J PHARMACOL, V168, P1736, DOI 10.1111/bph.12062 | eng |
hcfmusp.relation.reference | WEIBEL ER, 1963, LAB INVEST, V12, P131 | eng |
hcfmusp.relation.reference | Ye WJ, 2017, J THORAC DIS, V9, P2904, DOI 10.21037/jtd.2017.08.01 | eng |
hcfmusp.relation.reference | Yin YL, 2015, HUM IMMUNOL, V76, P775, DOI 10.1016/j.humimm.2015.09.037 | eng |
hcfmusp.relation.reference | Yoshizaki K, 2010, INHAL TOXICOL, V22, P610, DOI 10.3109/08958371003621633 | eng |
hcfmusp.relation.reference | Yun JM, 2014, J MED FOOD, V17, P407, DOI 10.1089/jmf.2013.2825 | eng |
dc.description.index | MEDLINE | eng |
dc.identifier.eissn | 1466-1861 | |
hcfmusp.citation.scopus | 24 | - |
hcfmusp.scopus.lastupdate | 2024-02-23 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MCM Artigos e Materiais de Revistas Científicas - FM/MPT Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - LIM/05 Artigos e Materiais de Revistas Científicas - LIM/20 Artigos e Materiais de Revistas Científicas - ODS/03 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_SANTANA_Inhibition_of_MAPK_and_STAT3SOCS3_by_Sakuranetin_Attenuated_2019.PDF | publishedVersion (English) | 7.88 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.